Stocktoria
Viking Therapeutics, Inc. VKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-04-29
Viking Therapeutics, Inc. statistics & valuation
Market cap$3.4B
P / B5.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -50.2% | -12.1% | -23.3% | -40.9% | -26.1% |
| Return on equity | -56.3% | -12.5% | -24.7% | -47.4% | -27.2% |
| Current ratio | 9.33 | 33.09 | 19.19 | 7.61 | 23.98 |
Source: SEC EDGAR filings · CIK 0001607678 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.